Showing results (131-140 of 147) with videos related to

Sort By:
Pageof 15
Obstetrics and Gynecology|March 24, 2009
Results from four rounds of ovarian cancer screening in a randomized trialEdward Partridge, Aimee R Kreimer, Robert T Greenlee, et al.
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|June 16, 2017
[Diagnosis and Surgical Treatment of Lung Ground-glass Opacities:a Review of 663 Cases]Shi-You Wei, Ke-Jia Zhao, Cheng-Lin Guo, et al.
Thoracic Cancer|January 23, 2019
Lymph node metastasis in Chinese patients with clinical T1 non-small cell lung cancer: A multicenter real-world observational studyBing Chen, Xiaojun Wang, Xinnian Yu, et al.
Communications Biology|January 12, 2024
Single-cell profiling of the microenvironment in human bone metastatic renal cell carcinomaFen Ma, Shuoer Wang, Lun Xu, et al.
CNS Neuroscience & Therapeutics|January 23, 2015
Surgical stress induces brain-derived neurotrophic factor reduction and postoperative cognitive dysfunction via glucocorticoid receptor phosphorylation in aged miceXiao-Sheng Tian, Ya-Wei Tong, Zheng-Qian Li, et al.
Cell Reports. Medicine|January 31, 2026
A pan-cancer single-cell transcriptomic atlas of human bone metastasesShuoer Wang, Fen Ma, Dongliang Wang, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 15, 2025
Baicalein relieves lung graft ischemia-reperfusion injury by reducing advanced glycation endproducts: From screens to mechanismsDong Tian, Xiang-Yun Zheng, Sen-Lin Hou, et al.
Annals of Family Medicine|May 13, 2009
Cumulative incidence of false-positive results in repeated, multimodal cancer screeningJennifer Miller Croswell, Barnett S Kramer, Aimee R Kreimer, et al.
Zhonghua Yi Xue Za Zhi|February 16, 2012
[Cross-sectional study of current situation of glycemic control with type 1 diabetes in Guangdong Province]Hong-rong Deng, Ge Wu, Guo-chun Luo, et al.
The Lancet. Oncology|November 28, 2017
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 studyWen-Zhao Zhong, Qun Wang, Wei-Min Mao, et al.
Pageof 15